iShares Biotechnology ETF Rating $169.84 -2.34 (-1.36%) As of 02:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.73Holdings in IBB have an aggregate rating of Moderate Buy based on 530 analyst ratings issued in the past year covering 25 companies (65.7% of the portfolio).IBB Aggregate Price Target$169.08-0.45% DownsideHigh Prediction$169.08Average Prediction$169.08Low Prediction$169.08Holdings in IBB have an aggregate price target of $169.08 and a range of $169.08 to $169.08 covering 25 companies (65.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.52%GILDGilead Sciences$131.07-2.5%4.8322 of 5 stars2.90$156.93 19.7%29Positive NewsAnalyst Forecast7.37%VRTXVertex Pharmaceuticals$437.49-2.2%4.574 of 5 stars2.88$555.91 27.1%25Positive NewsAnalyst Downgrade7.25%AMGNAmgen$329.71-2.1%4.3666 of 5 stars2.48$355.19 7.7%31Positive News5.93%REGNRegeneron Pharmaceuticals$602.78-2.0%4.9232 of 5 stars2.70$792.65 31.5%273.61%ALNYAlnylam Pharmaceuticals$300.31-0.6%4.4434 of 5 stars2.85$463.13 54.2%26Positive News3.49%ARGXargenex$837.12+0.1%4.0503 of 5 stars2.92$1,019.50 21.8%24Analyst Forecast2.68%BIIBBiogen$192.34-1.9%3.4332 of 5 stars2.52$215.81 12.2%292.48%NTRANatera$222.09-0.6%3.9411 of 5 stars2.79$256.60 15.5%192.44%RVMDRevolution Medicines$164.61+4.5%2.5224 of 5 stars3.00$122.78 -25.4%22News CoverageAnalyst Forecast2.24%UTHRUnited Therapeutics$546.40-1.9%4.2771 of 5 stars2.85$619.42 13.4%13Insider Trade2.10%INSMInsmed$105.10-1.7%3.7903 of 5 stars2.96$210.95 100.7%25Positive NewsGap Up2.07%ILMNIllumina$163.92+0.6%2.1767 of 5 stars2.28$138.38 -15.6%18Positive NewsAnalyst Forecast1.98%ONCBeOne Medicines$274.61-4.6%4.2498 of 5 stars2.80$389.15 41.7%151.78%INCYIncyte$95.69-1.1%4.3554 of 5 stars2.41$104.00 8.7%221.60%MRNAModerna$46.21-2.1%1.4939 of 5 stars1.84$35.73 -22.7%191.41%NBIXNeurocrine Biosciences$160.99+1.7%4.3345 of 5 stars2.83$186.05 15.6%23Analyst ForecastInsider Trade1.34%ROIVRoivant Sciences$29.58-1.4%2.8797 of 5 stars2.75$33.59 13.6%12Positive NewsGap Down1.18%GMABGenmab A/S$25.66-2.5%4.0416 of 5 stars2.75$37.93 47.8%12Gap Down1.17%EXELExelixis$50.37-0.2%2.7008 of 5 stars2.39$47.35 -6.0%23Analyst Revision1.15%IONSIonis Pharmaceuticals$75.46-1.4%3.2925 of 5 stars2.90$100.90 33.7%211.02%MDGLMadrigal Pharmaceuticals$486.84-2.1%2.9155 of 5 stars2.78$687.00 41.1%18Positive NewsAnalyst Forecast1.02%BBIOBridgeBio Pharma$65.97-0.4%3.4839 of 5 stars2.84$88.90 34.8%25High Trading Volume1.00%ASNDAscendis Pharma A/S$221.21-1.3%4.5352 of 5 stars3.00$295.39 33.5%19Short Interest Decrease0.96%ARWRArrowhead Pharmaceuticals$75.81-2.7%2.9929 of 5 stars2.75$87.80 15.8%12Positive NewsAnalyst Downgrade0.93%AXSMAxsome Therapeutics$229.55-2.1%2.5357 of 5 stars2.90$251.26 9.5%21 This page (NASDAQ:IBB) was last updated on 6/1/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts